Results obtained have clearly shown that MVA-B infection induces a strong cytotoxic activity by stimulated CD8+ T lymphocytes (69.8% reduction of target cells), thus demonstrating that the combination of MDDC and MVA-B is able to destroy the main target cells where HIV replicates, which could be used as a direct marker of the efficacy of vaccine candidates [76]. Here, CD8A is linked to infection.